Cambridge, Mass.-based Biogen paid Carlsbad, Calif.-based Ionis $5 million as part of the companies' collaboration to develop drugs for neurologic diseases.
Spinal Tech
Following successful study, Intralink-Spine promotes Rejuve as low back pain cure — 5 things to know
Lexington, Ky.,-based Intralink-Spine is optimistic after its Rejuve treatment showed positive results in a six-month study.
Knoxville, Tenn.-based ChoiceSpine acquired Gainesville, Fla.-based Exactech's spine products business.
Carlsbad, Calif.-based SeaSpine is commercially launching its Vu a•POD Prime NanoMetalene System.
Zimmer Biomet Holdings has announced its fourth quarter and full year financial results for 2016.
Advertisement
President Donald Trump met with pharmaceutical executives earlier this week, according to U.S. News and World Report.
Last year there were fewer FDA approvals and it took longer for medical devices to achieve approved status; however with President Donald Trump's vows to eliminate wasteful regulations that could change in 2017, according to Seeking Alpha.
Gateway Investment Advisers, owner of $2,560,000-worth Stryker shares, has cut back its stake in shares in the company.
Transparency Market Research reports that the development of robotic spine surgery systems has combined with other factors to improve the market's prospects heading into the future.
The global neurology endoscopy devices market is set to grow at a compound annual growth rate of more than 7 percent between 2017 and 2021, a Technavio report found.